How Testosterone Enanthate Affects Creatinine

Serum creatinine is a function of muscle mass and renal filtration. Testosterone enanthate affects both ends:

1. Increased muscle mass and turnover: Creatinine is produced by skeletal muscle from the non-enzymatic breakdown of creatine and phosphocreatine. More muscle means more daily creatinine production. On TRT, lean mass gains of 2 to 5 kg in the first six months are typical, and this alone can shift serum creatinine 5 to 10 percent upward without any change in actual kidney function.
2. Modest RAAS activation: Testosterone, like other AAS, upregulates the renin-angiotensin system to a lesser degree than 19-nor compounds (Rocha et al., 2007, PMID 17906098). The hemodynamic effect on the kidney is mild but measurable.
3. Subclinical glomerular stress: Long-term AAS users carry elevated urine ACR and lower cystatin C-based eGFR, even when creatinine looks normal (Ozkurt et al., 2023, PMID 37680426). The muscle-driven creatinine increase can mask early kidney injury, which is why cystatin C and urine ACR matter more in this population than in sedentary patients.

Net effect: a modest, usually benign creatinine rise on standard TRT that mostly reflects muscle mass, with a small contribution from RAAS-mediated hemodynamics.

Replacement doses (100 to 200 mg/week):

• Creatinine typically rises 5 to 15 percent above pre-TRT baseline within the first six months
• Most men land between 0.9 and 1.3 mg/dL (80 to 115 umol/L)
• Stable once lean mass plateaus, usually around month 6 to 12
• eGFR calculated from creatinine drops correspondingly, often shifting from 100 to 85 mL/min/1.73m^2; this is largely an artefact, not real GFR loss

Supraphysiological doses (300 to 600+ mg/week):

• Creatinine can climb 15 to 30 percent above baseline
• Driven by faster lean mass gains and additional RAAS contribution
• Difficult to distinguish artefact from real renal stress without cystatin C or urine ACR

The interpretation trap: A 25 percent creatinine rise from 0.9 to 1.13 mg/dL on TRT is usually benign muscle artefact. A 25 percent rise from 1.4 to 1.75 mg/dL with rising urine ACR and unchanged cystatin C is real renal stress. Without cystatin C and urine ACR, you cannot tell the difference reliably.

Baseline before starting TRT: Pull creatinine, eGFR, cystatin C, and urine ACR. This is the only window to capture true baseline kidney function before muscle mass starts shifting the creatinine signal.

First year on TRT:

• Repeat creatinine and eGFR at 3 months
• Add cystatin C at 6 months if creatinine has risen more than 15 percent
• Add urine ACR if cystatin C-based eGFR diverges meaningfully from creatinine-based eGFR

Long-term cadence:

• Annual creatinine, eGFR, cystatin C, urine ACR on stable TRT
• Repeat sooner if blood pressure rises, haematocrit climbs above 52, or new medications are added (NSAIDs, ARBs, ACE inhibitors)

Action thresholds:

• Creatinine rise over 30 percent from baseline that does not stabilise: investigate (cystatin C, urine ACR, ultrasound)
• New microalbuminuria (urine ACR over 30 mg/g): work up regardless of creatinine
• Cystatin C-based eGFR below 60 mL/min/1.73m^2: refer to nephrology

Reducing renal stress on TRT:

• Keep blood pressure under 130/80 on cycle; this is the single biggest renal protection lever
• Maintain haematocrit under 52; high viscosity raises intra-glomerular pressure
• Limit chronic NSAID use; ibuprofen and naproxen blunt the prostaglandins that protect renal blood flow during BP changes
• Hydrate adequately, especially during cutting phases or when using diuretics

Interpreting a 10 to 20 percent creatinine bump:

• Cross-check with cystatin C, which is muscle-mass-independent
• Check urine ACR, the earliest signal of glomerular damage
• If both are normal, the creatinine rise is muscle artefact, not kidney injury
• If either is abnormal, work up the kidney before adding any new compound

When to add telmisartan for renoprotection:

• Blood pressure above 130/80 on TRT
• Urine ACR above 30 mg/g
• Cystatin C-based eGFR dropping over 5 mL/min/year on stable TRT
• All three indicate the kidney is under stress that an ARB can ameliorate (RENAAL, Brenner et al., 2001, PMID 11565518)